ArticleResearch square2023

Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers.

Kris Wood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.